Literature DB >> 31014933

Informed decision-making based on a leaflet in the context of prostate cancer screening.

Tessa Dierks1, Eveline A M Heijnsdijk2, Ida J Korfage2, Monique J Roobol3, Harry J de Koning2.   

Abstract

OBJECTIVE: We aimed to assess to what extent men make informed choices in the context of prostate cancer screening and how written material contributes to that process.
METHODS: We developed a leaflet describing prostate cancer screening, and a questionnaire consisting of knowledge, attitude, and intended screening uptake components to assess informed decision-making. The leaflet and questionnaire were pilot-tested among men of the target population, adapted accordingly, and sent to 761 members of an online research panel. We operationalized whether the leaflet was read as spending one minute on the leaflet page and by a self-reported answer of respondents.
RESULTS: The response rate was 66% (501/761). The group who read the leaflet (n = 342) correctly answered a knowledge item significantly more often (10.9 versus 8.8; p < 0.001) than those who did not read the leaflet (n = 159), and made more informed choices (73% versus 56%; p = 0.001). There were no significant differences in attitude and intended screening uptake between both groups.
CONCLUSION: Having read the leaflet could be one of the factors associated with increased levels of knowledge and informed decision-making. PRACTICAL IMPLICATIONS: The results of this study showed that increasing knowledge and supporting informed decision-making with written material are feasible in prostate cancer screening.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Informed choice; Informed decision-making; Leaflet; Mass screening; Prostate cancer screening

Mesh:

Year:  2019        PMID: 31014933      PMCID: PMC6800081          DOI: 10.1016/j.pec.2019.03.009

Source DB:  PubMed          Journal:  Patient Educ Couns        ISSN: 0738-3991


  30 in total

1.  Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years.

Authors:  Anne Andermann; Ingeborg Blancquaert; Sylvie Beauchamp; Véronique Déry
Journal:  Bull World Health Organ       Date:  2008-04       Impact factor: 9.408

2.  What influences the decision to participate in colorectal cancer screening with faecal occult blood testing and sigmoidoscopy?

Authors:  L van Dam; I J Korfage; E J Kuipers; L Hol; A H C van Roon; J C I Y Reijerink; M van Ballegooijen; M E van Leerdam
Journal:  Eur J Cancer       Date:  2013-04-06       Impact factor: 9.162

3.  Women's understanding of a "normal smear test result": experimental questionnaire based study.

Authors:  T M Marteau; V Senior; P Sasieni
Journal:  BMJ       Date:  2001-03-03

Review 4.  Prostate Cancer Screening.

Authors:  Mary Weinstein Dunn
Journal:  Semin Oncol Nurs       Date:  2017-03-23       Impact factor: 2.315

5.  Informed choice on Pap smear still limited by lack of knowledge on the meaning of false-positive or false-negative test results.

Authors:  Ida J Korfage; Marjolein van Ballegooijen; Brendy Wauben; J Dik F Habbema; Marie-Louise Essink-Bot
Journal:  Patient Educ Couns       Date:  2011-01-26

6.  How to improve the readability of the patient package leaflet: a survey on the use of colour, print size and layout.

Authors:  C Bernardini; V Ambrogi; G Fardella; L Perioli; G Grandolini
Journal:  Pharmacol Res       Date:  2001-05       Impact factor: 7.658

7.  Screening and prostate-cancer mortality in a randomized European study.

Authors:  Fritz H Schröder; Jonas Hugosson; Monique J Roobol; Teuvo L J Tammela; Stefano Ciatto; Vera Nelen; Maciej Kwiatkowski; Marcos Lujan; Hans Lilja; Marco Zappa; Louis J Denis; Franz Recker; Antonio Berenguer; Liisa Määttänen; Chris H Bangma; Gunnar Aus; Arnauld Villers; Xavier Rebillard; Theodorus van der Kwast; Bert G Blijenberg; Sue M Moss; Harry J de Koning; Anssi Auvinen
Journal:  N Engl J Med       Date:  2009-03-18       Impact factor: 91.245

8.  A decision aid to support informed choices about bowel cancer screening among adults with low education: randomised controlled trial.

Authors:  Sian K Smith; Lyndal Trevena; Judy M Simpson; Alexandra Barratt; Don Nutbeam; Kirsten J McCaffery
Journal:  BMJ       Date:  2010-10-26

9.  Evaluation of an informed choice invitation for type 2 diabetes screening.

Authors:  Ian Kellar; Stephen Sutton; Simon Griffin; A Toby Prevost; Ann Louise Kinmonth; Theresa M Marteau
Journal:  Patient Educ Couns       Date:  2008-06-02

Review 10.  Cost-effectiveness of prostate cancer screening: a systematic review of decision-analytical models.

Authors:  Sabina Sanghera; Joanna Coast; Richard M Martin; Jenny L Donovan; Syed Mohiuddin
Journal:  BMC Cancer       Date:  2018-01-18       Impact factor: 4.430

View more
  1 in total

1.  Chimeric cytokine receptor enhancing PSMA-CAR-T cell-mediated prostate cancer regression.

Authors:  Shao Weimin; Asimujiang Abula; Ding Qianghong; Wang Wenguang
Journal:  Cancer Biol Ther       Date:  2020-03-25       Impact factor: 4.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.